Structured visit summaries for a 45-provider primary care group.

You manage a multi-site family medicine group with 18,000 active patients across four clinics. Your days are consumed by primary care, chronic disease management, and same-day sick visits.

Behind the scenes, your front desk and nursing staff are constantly coordinating referrals and prior authorizations. Your marketing coordinator might be playing around with ChatGPT to draft patient education blogs, and you have a small ambient scribe pilot running in just two exam rooms. The tools exist, but there is no enterprise rollout.

The real friction is clinical documentation. It takes your physicians 15 to 20 minutes to complete post-visit charting. When flu season hits and the waiting rooms fill up, same-day note completion drops drastically.

Referral letters and prior authorization narratives are also being retyped from scratch, forcing nursing staff to chase missing clinical details. That becomes a separate follow-on opportunity, but the immediate burnout problem is physician charting time.

You know AI scribes and summary generators could fix this tomorrow, but the barrier is massive: HIPAA. Your compliance officer points out that putting Protected Health Information (PHI) into an unvetted tool is a fast track to a massive fine.

There is anxiety around BAA (Business Associate Agreement) requirements and audit logging. The prevailing sentiment is simply, "AI cannot touch PHI," leaving your physicians stuck typing late into the evening.

Instead of listening to aggressive sales pitches from ambient scribe vendors, Dr. Vasquez (your Medical Director) and Sarah (your Compliance Officer) decide to evaluate the organization's actual readiness.

They use a structured framework to document the questions, requirements, and review gates they need to resolve before looking at software.

After inventorying ideas, the team selects a hero opportunity: AI-Assisted Visit Summary Drafts. The sample objective is to reduce charting time while keeping same-day completion high, but the assessment treats those numbers as targets to evaluate, not promised results.

Crucially, they decide the AI will only draft visit summaries from structured EHR fields—it will never auto-sign a chart, and raw audio is excluded from Phase 1.

The diagnostic assessment flags "Data & Information" and "Risk & Security" as areas of significant concern. PHI is everywhere in the proposed workflow.

The team acknowledges that physician skepticism is high, and staff need clear rules about what data can and cannot be sent to any AI system.

The ordeal is establishing non-negotiable guardrails. The sample assessment records that no PHI can enter an AI tool unless the organization has appropriate vendor terms and compliance review.

Physicians must review all AI-generated clinical text before chart sign-off. The team also records that any expansion beyond an initial limited group would require medical director review.

The sample report captures a limited trial concept for three physicians at the Main Street clinic, including stop conditions for uncorrected clinical errors or any HIPAA incident.

By prioritizing compliance gates over vendor hype, the clinic has a clearer assessment record for medical-director and board discussion before any implementation decision.